IFNG and cancer: While both Vγ4+ and Vγ6+ subsets have been shown to produce IL-17, Vγ6+ cells produce IL-17 exclusively, and augment production in the context of cancer or inflammation whereas Vγ4+ are more heterogeneous and can produce IFN-γ or IL-17 depending upon environmental context.